Ex Vivo CD34+–Selected T Cell–Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response
Pere Barba, Patrick Hilden, Sean M. Devlin, Molly Maloy, Djamilia Dierov, Jimmy Nieves, Matthew D. Garrett, Julie Sogani, Christina Cho, Juliet N. Barker, Nancy A. Kernan, Hugo Castro-Malaspina, Ann A. Jakubowski, Guenther Koehne, Esperanza B. Papadopoulos, Susan Prockop, Craig Sauter, Roni Tamari, Marcel R.M. van den Brink, Scott T. AvecillaRichard Meagher, Richard J. O'Reilly, Jenna D. Goldberg, James W. Young, Sergio Giralt, Miguel Angel Perales, Doris M. Ponce
Dive into the research topics of 'Ex Vivo CD34+–Selected T Cell–Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response'. Together they form a unique fingerprint.